Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Bioventus Inc. (BVS) Institutional Ownership & Insider Trading

157 institutions reported holding Bioventus Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 3 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

BVSBioventus Inc.Follow BVS — free
Medical Devices · Healthcare
—
Price chart with a free account
Market cap
1.3B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
10 Nov, in 17 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

157 institutions held 71.2% of the shares. Across filers that reported both quarters, shares held changed +17.5%.

Increased+74New+22Decreased-37Closed-20

Largest moves, shares (millions)

Nantahala Capital Management+5.9MAmerican Century Companies+0.7MWellington Management Group+0.6MEssex Investment Management-0.6MD. E. Shaw-0.3MSei Investments-0.2M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
+0.2Sep 24+0.2Dec 24+2.1Mar 25+1.5Jun 25+0.9Sep 25+1.5Dec 25+1.0Mar 26+8.9Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2615760+17.5%74223720
Mar 2615751+2.0%53234313
Dec 2514750+3.1%53233512
Sep 2513249+1.9%36224624
Jun 2513348+3.3%65202630
Mar 2514447+4.7%51164119
Dec 2415046+0.5%41314817
Sep 2413745+0.5%37462314

Bioventus Inc. — questions

Who owns Bioventus Inc. stock?
157 institutions reported Bioventus Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: Essex Woodlands Management, Inc. (15.5%), Nantahala Capital Management, LLC (14.3%), Juniper Investment Company, LLC (8.3%).
Are Bioventus Inc. insiders buying or selling?
3 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Bioventus Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.